Quantum-Si incorporated (QSI)
| Market Cap | 206.09M |
| Revenue (ttm) | 3.18M |
| Net Income (ttm) | -116.85M |
| Shares Out | 215.49M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,595,523 |
| Open | 0.979 |
| Previous Close | 1.010 |
| Day's Range | 0.950 - 1.000 |
| 52-Week Range | 0.887 - 3.100 |
| Beta | 2.99 |
| Analysts | Buy |
| Price Target | 1.50 (+56.84%) |
| Earnings Date | Mar 3, 2026 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an ava... [Read more]
Financial Performance
In 2024, Quantum-Si incorporated's revenue was $3.06 million, an increase of 182.62% compared to the previous year's $1.08 million. Losses were -$101.01 million, 5.26% more than in 2023.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price target is $1.5, which is an increase of 56.84% from the latest price.
News
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026.
Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Release of Two New Manuscripts.
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements.
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Highlights Significant Development Advancements for ProteusTM and Industry Leading Technology Pipeline at Investor & Analyst Day.
Quantum-Si incorporated (QSI) Analyst/Investor Day Transcript
Quantum-Si incorporated ( QSI) Analyst/Investor Day November 19, 2025 10:00 AM EST Company Participants Jeffrey Hawkins - President, CEO & Director Todd Rearick - Chief Technology Officer John Viecel...
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day
BRANFORD, Conn.--(BUSINESS WIRE)--QSI to Highlight Significant Proteus™ Platform Dev Progress & Provide Insights into Company's Industry Leading Tech Pipeline at Investor & Analyst Day.
Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript
Quantum-Si incorporated ( QSI) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Risa Lindsay Jeffrey Hawkins - President, CEO & Director Jeffry Keyes - CFO & Treasurer Conferen...
Quantum-Si Reports Third Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2025 Financial Results. Announces Successful Sequencing on Prototype Proteus Unit, Development Program is On-Track.
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025.
Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
BRANFORD, Conn--(BUSINESS WIRE)--Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025.
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing.
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference.
Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit.
Quantum-Si incorporated (QSI) Q2 2025 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Jeffrey Alan Hawkins - President, CEO & Director Jeffry R. Keyes - CFO & Treasurer...
Quantum-Si Reports Second Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2025 Financial Results.
Quantum-Si Stock: A Small Position Is Warranted (Technical Analysis)
Quantum-Si shows bullish technical signals: trading above its 30-week EMA, strong momentum, positive volume trends, and outperforming the S&P 500 since April. Upcoming earnings are a key catalyst. Sur...
Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference.
Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025.
Tesla, Quantum-Si And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock.
Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives.
Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Join Leading Experts from DNAnexus, Olink, & Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration & Standardization.
Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston.